Barclays PLC Tyme Technologies, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$0.28 - $0.68 $16,089 - $39,073	-57,461 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.04 $5,155 - $8,935	-8,592 Reduced 13.01%	57,461 $35,000
Q3 2021 Nov 09, 2021	SELL	$0.99 - $1.38 $42,490 - $59,229	-42,920 Reduced 39.39%	66,053 $68,000
Q2 2021 Aug 13, 2021	BUY	$1.14 - $1.87 $19,757 - $32,408	17,331 Added 18.91%	108,973 $137,000
Q1 2021 May 13, 2021	BUY	$1.34 - $3.53 $92,746 - $244,325	69,214 Added 308.61%	91,642 $163,000
Q4 2020 Feb 11, 2021	SELL	$0.87 - $1.26 $7,602 - $11,009	-8,738 Reduced 28.04%	22,428 $27,000
Q3 2020 Nov 12, 2020	SELL	$0.93 - $1.35 $4,735 - $6,874	-5,092 Reduced 14.04%	31,166 $30,000
Q2 2020 Aug 12, 2020	BUY	$0.97 - $1.7 $15,876 - $27,825	16,368 Added 82.29%	36,258 $48,000
Q1 2020 May 13, 2020	SELL	$0.9 - $1.95 $35,235 - $76,342	-39,150 Reduced 66.31%	19,890 $22,000
Q4 2019 Feb 10, 2020	BUY	$1.0 - $1.49 $29,821 - $44,433	29,821 Added 102.06%	59,040 $83,000
Q3 2019 Nov 14, 2019	SELL	$0.97 - $1.77 $39,647 - $72,346	-40,874 Reduced 58.31%	29,219 $35,000
Q2 2019 Aug 14, 2019	BUY	$0.96 - $1.89 $38,143 - $75,095	39,733 Added 130.87%	70,093 $85,000
Q1 2019 May 15, 2019	BUY	$1.76 - $3.73 $53,433 - $113,242	30,360 New	30,360 $53,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.21 $32,149 - $67,338	-15,995 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.18 - $3.44 $28,150 - $44,420	12,913 Added 418.98%	15,995 $45,000
Q2 2018 Aug 14, 2018	BUY	$2.05 - $4.09 $6,318 - $12,605	3,082 New	3,082 $9,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.